Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-31 5:17 pm Sale | 2023-08-31 | 13D | Pardes Biosciences, Inc. PRDS | FS Development Holdings II LLC | 1,000 100.000% | -16,812,146 (-99.99%) | Filing History |
| 2023-08-14 4:31 pm Purchase | 2023-08-02 | 13G | Pardes Biosciences, Inc. PRDS | Beryl Capital Management LLC | 4,859,426 7.800% | 4,859,426 (New Position) | Filing History |
| 2023-07-17 07:55 am Unchanged | 2023-07-16 | 13D | Pardes Biosciences, Inc. PRDS | FS Development Holdings II LLC | 16,813,146 27.240% | 0 (Unchanged) | Filing History |
| 2023-04-21 4:28 pm Unchanged | 2023-04-20 | 13D | Pardes Biosciences, Inc. PRDS | FS Development Holdings II LLC | 16,813,146 27.240% | 0 (Unchanged) | Filing History |
| 2023-04-06 9:07 pm Purchase | 2023-04-05 | 13D | Pardes Biosciences, Inc. PRDS | FS Development Holdings II LLC | 16,813,146 27.240% | 1,547,904 (+10.14%) | Filing History |
| 2023-02-14 4:45 pm Sale | 2022-12-31 | 13G | Pardes Biosciences, Inc. PRDS | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -4,431,901 (Position Closed) | Filing History |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | Pardes Biosciences, Inc. PRDS | T. Rowe Price Associates, Inc. | 6,166 0.000% | -3,206,309 (-99.81%) | Filing History |
| 2023-02-08 5:09 pm Unchanged | 2023-02-08 | 13G | Pardes Biosciences, Inc. PRDS | BML Investment Partners, L.P. | 4,867,984 7.800% | 0 (Unchanged) | Filing History |
| 2023-01-23 4:23 pm Purchase | 2023-01-13 | 13G | Pardes Biosciences, Inc. PRDS | Lynx1 Capital Management LP | 3,139,202 5.000% | 3,139,202 (New Position) | Filing History |
| 2022-12-30 5:30 pm Purchase | 2022-12-21 | 13G | Pardes Biosciences, Inc. PRDS | BML Investment Partners, L.P. | 4,867,984 7.800% | 4,867,984 (New Position) | Filing History |
| 2022-12-05 4:23 pm Purchase | 2022-12-01 | 13D | Pardes Biosciences, Inc. PRDS | FS Development Holdings II LLC | 15,265,242 24.490% | 637,420 (+4.36%) | Filing History |
| 2022-02-14 4:49 pm Purchase | 2021-12-31 | 13G | Pardes Biosciences, Inc. PRDS | VK Services LLC | 6,151,766 9.900% | 6,151,766 (New Position) | Filing History |
| 2022-02-07 4:01 pm Purchase | 2021-12-23 | 13D | Pardes Biosciences, Inc. PRDS | Lopatin Uri A | 5,697,287 9.100% | 5,697,287 (New Position) | Filing History |
| 2022-01-28 1:41 pm Purchase | 2021-12-31 | 13G | Pardes Biosciences, Inc. PRDS | Frazier Life Sciences Public Fund, L.P. | 2,457,507 3.900% | 2,457,507 (New Position) | Filing History |
| 2022-01-10 5:00 pm Purchase | 2021-12-29 | 13G | Pardes Biosciences, Inc. PRDS | RA CAPITAL MANAGEMENT L.P. | 4,431,901 7.100% | 4,431,901 (New Position) | Filing History |
| 2022-01-10 2:12 pm Purchase | 2021-12-31 | 13G | Pardes Biosciences, Inc. PRDS | T. Rowe Price Associates, Inc. | 3,212,475 5.100% | 3,212,475 (New Position) | Filing History |
| 2021-12-30 5:09 pm Purchase | 2021-12-23 | 13D | Pardes Biosciences, Inc. PRDS | FS Development Holdings II LLC | 14,627,822 23.450% | 14,627,822 (New Position) | Filing History |
| 2021-12-17 2:36 pm Purchase | 2021-12-07 | 13G | FS Development Corp. II FSII | Frazier Life Sciences Public Fund, L.P. | 1,113,700 5.400% | 1,113,700 (New Position) | Filing History |
| 2021-12-13 11:36 am Purchase | 2021-11-30 | 13G | FS Development Corp. II FSII | T. Rowe Price Associates, Inc. | 2,542,852 12.200% | 2,542,852 (New Position) | Filing History |